article thumbnail

DEA Promises Progress on Federal Cultivation Applications, But Provides No Timetable for Action

NORML

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.

DEA 167
article thumbnail

Hemp Litigation: DEA Sued Again

Canna Law Blog

The Canna Law Blog has been writing about the Drug Enforcement Agency’s (DEA) interim final rule (IFR) on hemp since its August publication in the Federal Register: Watch Out! The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids. The DEA Does Not Want You To Worry About Its New Hemp Rule.

DEA 93
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA Approves CBD-Containing Drug - Will the DEA Finally Step Up?

MJ Business Attorneys

Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. The FDA can make recommendations to the DEA about substances subjected to scheduling under the CSA, but the DEA is the entity with the power to reschedule CBD. In the recent case Hemp Industries Associations v.

DEA 113
article thumbnail

The Hemp Industry Responds to the DEA Rule With a Lawsuit

Canna Law Blog

On August 21, the Drug Enforcement Agency (the “DEA”) released an Interim Final Rule (the “ Rule ”), which, in part, suggests that in-process hemp extract shall be treated as a schedule I controlled substance during any point at which its THC concentration exceeds 0.3 percent on a dry weight basis. Emphasis added).

DEA 61
article thumbnail

Press Release: ACS Laboratory Launches Comprehensive Hemp Compliance Testing Panel

Cannabis Law Report

Using the data collected, ACS Laboratory extracted the strictest requirements per category to create the National Hemp Testing Panel and corresponding Certificate of Analysis. With that research, they created elaborate matrices to compare each mandate.

article thumbnail

Press Release: HAVN Life Successfully Exports Psilocybin from Jamaica Facility into the U.S. for Research Purposes

Cannabis Law Report

The importation of the naturally derived psilocybin into California was completed after the Company’s supply partner Mycrodose Therapeutics was granted an import license from the United States Drug Enforcement Administration (DEA). VANCOUVER, BC , Dec. 13, 2021 /CNW/ – Havn Life Sciences Inc. (CSE: Chief Executive Officer.

article thumbnail

Can I Import Marijuana Seeds to the U.S.?

Canna Law Blog

The seeds themselves have little to no THC, regardless of whether they were extracted from or may germinate into a plant that has more than 0.3% CBP is the federal agency responsible for ensuring that imported goods are allowed to enter only if they are in compliance with all applicable U.S. laws and regulations. federal law.

DEA 63